<code id='FFEB8DF97A'></code><style id='FFEB8DF97A'></style>
    • <acronym id='FFEB8DF97A'></acronym>
      <center id='FFEB8DF97A'><center id='FFEB8DF97A'><tfoot id='FFEB8DF97A'></tfoot></center><abbr id='FFEB8DF97A'><dir id='FFEB8DF97A'><tfoot id='FFEB8DF97A'></tfoot><noframes id='FFEB8DF97A'>

    • <optgroup id='FFEB8DF97A'><strike id='FFEB8DF97A'><sup id='FFEB8DF97A'></sup></strike><code id='FFEB8DF97A'></code></optgroup>
        1. <b id='FFEB8DF97A'><label id='FFEB8DF97A'><select id='FFEB8DF97A'><dt id='FFEB8DF97A'><span id='FFEB8DF97A'></span></dt></select></label></b><u id='FFEB8DF97A'></u>
          <i id='FFEB8DF97A'><strike id='FFEB8DF97A'><tt id='FFEB8DF97A'><pre id='FFEB8DF97A'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:345
          CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

          WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

          Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

          advertisement

          Pharmaceutical groups and patient advocates are increasingly fighting that approach.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Readout LOUD podcast, live from the STAT Breakthrough Summit East
          Readout LOUD podcast, live from the STAT Breakthrough Summit East

          Isthereacureforallergies?HastheFDAbecometooflexible?Andwhichdrugsmakeyoumuscular?Wecoverallthatandmo

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Bring on the sabbaticals for nurses

          AdobeA newstudy suggeststhatthenursingshortageiseasing,butthatdoesn’tmeanthehealthcaresystemcanstopw